350
Participants
Start Date
March 10, 2025
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2028
Alleviant ALV1 System
Creation of interatrial shunt
Sham-Control
Cardiac imaging
Stony Brook Medicine, New York
Rochester General Hospital, Rochester
Pinnacle Health Cardiovascular Institute, Harrisburg
Carilion Clinic, Roanoke
NC Heart and Vascular Research, Raleigh
Mission Hospital, Asheville
Medical University of South Carolina, Charleston
Atlanta VA Health Care System, Decatur
Ascension Sacred Heart, Pensacola
Tennova Healthcare - Turkey Creek Medical Center, Knoxville
Cleveland Clinic, Cleveland
Valencia Hospital Clinico, Valencia
Monument Health, Rapid City
Midwest Cardiovascular Institute, Naperville
Washington University - St Louis, St Louis
University Medical Center New Orleans, New Orleans
Cardiovascular Institute of the South, Houma
NextStage Clinical Research, Waco
Texas Cardiac Arrhythmia Research Foundation, Austin
Austin Heart, Austin
Hendrick Health, Abilene
Scripps Clinical Research Services, San Diego
University of California San Francisco, San Francisco
UC Davis Medical Center, Sacramento
Tufts Medical Center, Boston
Brigham and Women's Hospital, Boston
Boston Medical Center, Boston
Centre hospitalier de l'Universite de Montreal (CHUM), Montreal
Centre Integre Universitaire de Sainte et de Services Scoiiaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CIUSSS de l'Estrie - CHUS), Montreal
IUCPQ - Université Laval (Quebec), Québec
Tbilisi Heart and Vascular, Tbilisi
Hospital Clínico Universitario de Salamanca, Salamanca
Lead Sponsor
Alleviant Medical, Inc.
INDUSTRY